Summary
118.57 -0.23(-0.19%)11/18/2025
Zoetis Inc. (ZTS)
ZTS reported last earnings on 2025-11-04 after the market. An EPS of $1.7 was observed compared to an estimated EPS of $1.62, resulting in a surprise value of $0.08. A revenue of $2,400 million was observed compared to an estimated revenue of $2,410 million, resulting in a surprise value of $-10 Million.
Zoetis Inc. (ZTS)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| -0.19 | -1.10 | -17.25 | -21.73 | -27.04 | -31.76 | -23.98 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Fundamental Ratings
| Category | Rating |
| Main Rating | A- |
| Recommended Rating | Buy |
| DCF | Buy |
| ROE | Strong Buy |
| ROA | Strong Buy |
| Debt/Equity | Neutral |
| P/E | Sell |
| P/B | Strong Sell |
Earnings
| Trading Data | ||
| Close | 118.57 | |
| Open | 118.43 | |
| High | 119.13 | |
| Low | 117.09 | |
| Volume | 5,180,617 | |
| Change | -0.23 | |
| Change % | -0.19 | |
| Avg Volume (20 Days) | 4,309,215 | |
| Volume/Avg Volume (20 Days) Ratio | 1.20 | |
| 52 Week Range | 119.56 - 179.46 | |
| Price vs 52 Week High | -33.93% | |
| Price vs 52 Week Low | -0.83% | |
| Range | 0.00 | |
| Gap Up/Down | -1.19 | |
Profitibility | ||
| Market Capitalization (Mln) | 52,738 | |
| Revenue per share | 21.2170 | |
| Net Income per share | 5.9855 | |
| Dividend Yield | 0.0169 | |
| Dividend Share | 200.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | 19.7375 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |
11/15 10:00 EST - fool.com
2 Outstanding Dividend Stocks That Are Too Cheap to Ignore
Both stocks trade at once-in-a-decade low valuations and have all-time high dividend yields. Each company leads in its niche, but both are battling through minor challenges.
2 Outstanding Dividend Stocks That Are Too Cheap to Ignore
Both stocks trade at once-in-a-decade low valuations and have all-time high dividend yields. Each company leads in its niche, but both are battling through minor challenges.
11/15 03:44 EST - defenseworld.net
Analyzing Zoetis (NYSE:ZTS) and Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)
Zoetis (NYSE: ZTS - Get Free Report) and Shionogi and Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk,...
Analyzing Zoetis (NYSE:ZTS) and Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)
Zoetis (NYSE: ZTS - Get Free Report) and Shionogi and Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk,...
11/14 11:35 EST - forbes.com
Zoetis: A High-Quality Compounder Now On Sale?
Zoetis (ZTS) the world's largest animal-health company, develops and manufactures medicines, vaccines, and diagnostics for both pets and livestock. The stock has come under pressure in recent months as softer clinic traffic, uneven companion-animal demand, and a narrowed full-year outlook weighed...
Zoetis: A High-Quality Compounder Now On Sale?
Zoetis (ZTS) the world's largest animal-health company, develops and manufactures medicines, vaccines, and diagnostics for both pets and livestock. The stock has come under pressure in recent months as softer clinic traffic, uneven companion-animal demand, and a narrowed full-year outlook weighed...
11/14 08:03 EST - 247wallst.com
Pet Healthcare Spending Is Soaring. These Stocks Are Positioned to Clean Up
The steep increase in pet healthcare costs have doubled over the past five years, according to NPR.
Pet Healthcare Spending Is Soaring. These Stocks Are Positioned to Clean Up
The steep increase in pet healthcare costs have doubled over the past five years, according to NPR.
11/14 04:36 EST - defenseworld.net
Allianz SE Raises Holdings in Zoetis Inc. $ZTS
Allianz SE increased its stake in shares of Zoetis Inc. (NYSE: ZTS) by 30.5% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,923 shares of the company's stock after acquiring an additional 684...
Allianz SE Raises Holdings in Zoetis Inc. $ZTS
Allianz SE increased its stake in shares of Zoetis Inc. (NYSE: ZTS) by 30.5% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,923 shares of the company's stock after acquiring an additional 684...
11/13 12:41 EST - zacks.com
CPRX vs. ZTS: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical (CPRX) and Zoetis (ZTS). But which of these two stocks is more attractive to value investors?
CPRX vs. ZTS: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical (CPRX) and Zoetis (ZTS). But which of these two stocks is more attractive to value investors?
11/12 04:30 EST - defenseworld.net
Allworth Financial LP Buys 3,789 Shares of Zoetis Inc. $ZTS
Allworth Financial LP increased its stake in shares of Zoetis Inc. (NYSE: ZTS) by 8.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 47,179 shares of the company's stock after acquiring an additional...
Allworth Financial LP Buys 3,789 Shares of Zoetis Inc. $ZTS
Allworth Financial LP increased its stake in shares of Zoetis Inc. (NYSE: ZTS) by 8.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 47,179 shares of the company's stock after acquiring an additional...
11/12 03:40 EST - defenseworld.net
ABC Arbitrage SA Invests $2.24 Million in Zoetis Inc. $ZTS
ABC Arbitrage SA acquired a new stake in Zoetis Inc. (NYSE: ZTS) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 14,387 shares of the company's stock, valued at approximately $2,244,000. A number of other institutional...
ABC Arbitrage SA Invests $2.24 Million in Zoetis Inc. $ZTS
ABC Arbitrage SA acquired a new stake in Zoetis Inc. (NYSE: ZTS) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 14,387 shares of the company's stock, valued at approximately $2,244,000. A number of other institutional...
11/11 04:35 EST - fool.com
2 Dividend Stocks to Double Up on Right Now
Bad press has weighed on UnitedHealth Group and Zoetis. UnitedHealth Group faces controversy and investigations, but will likely survive and remain a key cog in America's healthcare system.
2 Dividend Stocks to Double Up on Right Now
Bad press has weighed on UnitedHealth Group and Zoetis. UnitedHealth Group faces controversy and investigations, but will likely survive and remain a key cog in America's healthcare system.
11/08 07:28 EST - seekingalpha.com
What Moved Markets This Week
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
What Moved Markets This Week
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
11/07 12:01 EST - seekingalpha.com
Zoetis: Why I'm Still Holding The Stock But Advise Against New Positions
Zoetis faces ongoing headwinds as Librela sales disappoint, triggering a sharp post-earnings sell-off and continued stock weakness. Librela's decline, fueled by social media concerns about side effects, overshadows growth in other segments and forces lowered revenue guidance. ZTS trades at a...
Zoetis: Why I'm Still Holding The Stock But Advise Against New Positions
Zoetis faces ongoing headwinds as Librela sales disappoint, triggering a sharp post-earnings sell-off and continued stock weakness. Librela's decline, fueled by social media concerns about side effects, overshadows growth in other segments and forces lowered revenue guidance. ZTS trades at a...
11/06 09:36 EST - seekingalpha.com
Zoetis Remains A Strong Buy Following Market Overreaction To Q3 Earnings
Zoetis Inc. is trading at historically low valuations despite continued EPS and margin growth, following a sharp post-earnings selloff. ZTS's Q3 results showed resilient profitability, but weaker guidance and slowing revenue growth triggered a market rerating from high to low growth. The company...
Zoetis Remains A Strong Buy Following Market Overreaction To Q3 Earnings
Zoetis Inc. is trading at historically low valuations despite continued EPS and margin growth, following a sharp post-earnings selloff. ZTS's Q3 results showed resilient profitability, but weaker guidance and slowing revenue growth triggered a market rerating from high to low growth. The company...
11/05 18:00 EST - gurufocus.com
Diamond Hill Capital's Strategic Moves: A Closer Look at Zoetis Inc.
Exploring Diamond Hill Capital (Trades, Portfolio)'s Latest 13F Filing for Q3 2025 Diamond Hill Capital (Trades, Portfolio) recently submitted its 13F filing f
Diamond Hill Capital's Strategic Moves: A Closer Look at Zoetis Inc.
Exploring Diamond Hill Capital (Trades, Portfolio)'s Latest 13F Filing for Q3 2025 Diamond Hill Capital (Trades, Portfolio) recently submitted its 13F filing f
11/04 16:16 EST - seekingalpha.com
Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript
Zoetis Inc. ( ZTS ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Steven Frank - Vice President of Investor Relations Kristin Peck - CEO & Director Wetteny Joseph - Executive VP & CFO Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division...
Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript
Zoetis Inc. ( ZTS ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Steven Frank - Vice President of Investor Relations Kristin Peck - CEO & Director Wetteny Joseph - Executive VP & CFO Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division...
11/04 13:15 EST - benzinga.com
Zoetis Stock Outlook Clouded By Rising Competitive Pressures
Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a third-quarter 2025 adjusted earnings per share of $1.70.
Zoetis Stock Outlook Clouded By Rising Competitive Pressures
Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a third-quarter 2025 adjusted earnings per share of $1.70.
11/04 12:46 EST - zacks.com
ZTS Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down
Zoetis tops Q3 earnings forecasts but misses on revenues and trims 2025 sales outlook, sending shares lower on weak U.S. results.
ZTS Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down
Zoetis tops Q3 earnings forecasts but misses on revenues and trims 2025 sales outlook, sending shares lower on weak U.S. results.
11/04 12:41 EST - seekingalpha.com
Zoetis: No Longer A Growth Stock
Zoetis shares have underperformed, falling over 25% in the past year, with recent guidance disappointing investors. Organic growth is slowing, especially in the United States, as core products reach market saturation and macro headwinds weigh on pet care spending. ZTS's valuation has compressed,...
Zoetis: No Longer A Growth Stock
Zoetis shares have underperformed, falling over 25% in the past year, with recent guidance disappointing investors. Organic growth is slowing, especially in the United States, as core products reach market saturation and macro headwinds weigh on pet care spending. ZTS's valuation has compressed,...
11/04 10:30 EST - zacks.com
Compared to Estimates, Zoetis (ZTS) Q3 Earnings: A Look at Key Metrics
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Zoetis (ZTS) Q3 Earnings: A Look at Key Metrics
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
11/04 09:11 EST - zacks.com
Zoetis (ZTS) Surpasses Q3 Earnings Estimates
Zoetis (ZTS) came out with quarterly earnings of $1.7 per share, beating the Zacks Consensus Estimate of $1.62 per share. This compares to earnings of $1.58 per share a year ago.
Zoetis (ZTS) Surpasses Q3 Earnings Estimates
Zoetis (ZTS) came out with quarterly earnings of $1.7 per share, beating the Zacks Consensus Estimate of $1.62 per share. This compares to earnings of $1.58 per share a year ago.
11/04 08:59 EST - barrons.com
This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps.
Zoetis slashes its full-year outlook.
This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps.
Zoetis slashes its full-year outlook.
Market News
×
Loading news…